Jit Mark, Dang Thi Thanh Huyen, Friberg Ingrid, Hoang Van Minh, Pham Huy Tuan Kiet, Walker Neff, Nguyen Van Cuong, Tran Nhu Duong, Toda Kohei, Hutubessy Raymond, Fox Kimberley, Nguyen Tran Hien
Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK; Modelling and Economics Unit, Public Health England, London, UK.
National Institute of Hygiene and Epidemiology, Hanoi, Vietnam.
Vaccine. 2015 May 7;33 Suppl 1(Suppl 1):A233-9. doi: 10.1016/j.vaccine.2014.12.017.
Countries like Vietnam transitioning to middle-income status increasingly bear the cost of both existing and new vaccines. However, the impact and cost-effectiveness of the Expanded Programme on Immunization (EPI) as a whole has never been assessed on a country level.
Data on vaccine-preventable disease incidence and mortality from Vietnam's national surveillance was analysed to estimate the likely impact that vaccination in 1980-2010 may have had. Adjustment for under-reporting was made by examining trends in reported mumps incidence and in case-fatality risks for each disease. The same data were separately analysed using the Lives Saved Tool (LiST) to give an alternative estimate of impact. The financial cost of EPI in 1996-2010 was also estimated from the perspective of service provider.
National surveillance data suggests that up to 5.7 million diseases cases and 26,000 deaths may have been prevented by EPI. Analysis using LiST suggests that even more deaths (370,000) may have been prevented by measles and pertussis vaccination alone. The cost-effectiveness of EPI is estimated to be around $1000-$27,000 per death prevented.
Two separate approaches to assessing EPI impact in Vietnam give different quantitative results but a common conclusion: that EPI has made a substantial impact on mortality and represents good value for money.
像越南这样正迈向中等收入水平的国家,日益承担着现有疫苗和新疫苗的成本。然而,扩大免疫规划(EPI)作为一个整体,其影响和成本效益从未在国家层面进行过评估。
分析了越南国家监测中疫苗可预防疾病的发病率和死亡率数据,以估计1980 - 2010年期间疫苗接种可能产生的影响。通过检查报告的腮腺炎发病率趋势和每种疾病的病死率风险来对报告不足进行调整。使用挽救生命工具(LiST)对相同数据进行单独分析,以给出影响的另一种估计。还从服务提供者的角度估计了1996 - 2010年期间EPI的财务成本。
国家监测数据表明,EPI可能预防了多达570万例疾病和2.6万例死亡。使用LiST进行的分析表明,仅麻疹和百日咳疫苗接种就可能预防了更多的死亡(37万例)。EPI的成本效益估计为每预防一例死亡约1000 - 27000美元。
评估越南EPI影响的两种不同方法得出了不同的定量结果,但有一个共同结论:EPI对死亡率产生了重大影响,且性价比高。